Real‐world outcomes of ventricular tachycardia catheter ablation with versus without intracardiac echocardiography

2019 ◽  
Vol 31 (2) ◽  
pp. 417-422
Author(s):  
Michael E. Field ◽  
Michael R. Gold ◽  
Matthew R. Reynolds ◽  
Laura Goldstein ◽  
Stephanie Hsiao Yu Lee ◽  
...  
Keyword(s):  
Ventricular Tachycardia ◽  
Catheter Ablation ◽  
Real World ◽  
Intracardiac Echocardiography

Intracardiac echocardiography use and outcomes after catheter ablation of ventricular tachycardia

2020 ◽  
Vol 9 (5) ◽  
pp. 375-385
Author(s):  
Michael E Field ◽  
Laura Goldstein ◽  
Stephanie Hsiao Yu Lee ◽  
Iftekhar Kalsekar ◽  
Paul Coplan ◽  
...  
Keyword(s):  
Ventricular Tachycardia ◽  
Catheter Ablation ◽  
Cardiac Resynchronization Therapy ◽  
Implantable Cardioverter Defibrillator ◽  
Lower Risk ◽  
Intracardiac Echocardiography ◽  
Cardiac Resynchronization ◽  
Resynchronization Therapy ◽  
Cardioverter Defibrillator ◽  
Procedure Codes

Aim: To compare outcomes among patients with implantable cardioverter defibrillator/cardiac resynchronization therapy-defibrillator undergoing outpatient ventricular tachycardia (VT) catheter ablation using intracardiac echocardiography (ICE) versus no ICE. Patients & methods: Patients were classified into ICE (n = 1143)/non-ICE (n = 1677) groups based on ICE procedure codes. Patients in each group were propensity matched on study covariates. Survival analyses were used to assess outcomes. To examine residual confounding, falsification outcomes were evaluated. Results: ICE patients had a 24% lower risk of all-cause readmissions, 24% lower risk of cardiovascular-related and 20% lower risk of VT-related readmissions compared with non-ICE patients. Falsification analyses for ICE use association were nonsignificant. Conclusion: Patients with implantable cardioverter defibrillator/cardiac resynchronization therapy-defibrillator undergoing VT ablation with ICE use had significantly lower likelihood of VT-related readmission.

scholarly journals 1150-152 Utility of intracardiac echocardiography to guide radiofrequency catheter ablation of ventricular tachycardia of different etiologies

2004 ◽  
Vol 43 (5) ◽  
pp. A359 ◽  
Author(s):  
Monique R.M Jongbloed ◽  
Jeroen J Bax ◽  
Philippine Kies ◽  
Alida E Borger van der Burg ◽  
Katja Zeppenfeld ◽  
...  
Keyword(s):  
Ventricular Tachycardia ◽  
Catheter Ablation ◽  
Radiofrequency Catheter Ablation ◽  
Intracardiac Echocardiography

Catheter Ablation of Ventricular Tachycardia in the Presence of an Old Endocavitary Thrombus Guided by Intracardiac Echocardiography

2016 ◽  
Vol 39 (6) ◽  
pp. 581-587 ◽  
Author(s):  
PETR PEICHL ◽  
DAN WICHTERLE ◽  
ROBERT ČIHÁK ◽  
BASHAR ALDHOON ◽  
JOSEF KAUTZNER
Keyword(s):  
Ventricular Tachycardia ◽  
Catheter Ablation ◽  
Intracardiac Echocardiography

scholarly journals Long-term follow-up of normal and structural heart ventricular tachycardia catheter ablation: real-world experience from a UK tertiary centre

Open Heart ◽  
2019 ◽  
Vol 6 (2) ◽  
pp. e000996
Author(s):  
Ahmed M Adlan ◽  
Aruna Arujuna ◽  
Rory Dowd ◽  
Sajad Hayat ◽  
Sandeep Panikker ◽  
...  
Keyword(s):  
Ventricular Tachycardia ◽  
Catheter Ablation ◽  
Real World ◽  
Primary Outcome ◽  
Normal Heart ◽  
Tertiary Centre ◽  
Vt Ablation ◽  
Procedural Success

BackgroundVentricular tachycardia (VT) is associated with increased morbidity and mortality. There is growing evidence for the effectiveness of catheter ablation in improving outcomes in patients with recurrent VT. Consequently the threshold for referral for VT ablation has fallen over recent years, resulting in increased number of procedures.ObjectiveTo evaluate the effectiveness and safety of VT ablation in a real-world tertiary centre setting.MethodsThis is a prospective analysis of all VT ablation cases performed at University Hospital Coventry. Follow-up data were obtained from review of electronic medical records and patient interview. The primary endpoint for normal heart VT was death, cardiovascular hospitalisation and VT recurrence, and for structural heart VT was arrhythmic death, VT storm (>3 episodes within 24 hours) or appropriate shock.ResultsForty-seven patients underwent 53 procedures from January 2012 to January 2018. The mean age ±SD was 57±15 years, 68% were male, 81% were Caucasian and 66% were elective cases. The aetiology of VT included normal heart (49%), ischaemic cardiomyopathy (ICM, 36%), dilated cardiomyopathy (9%), hypertrophic cardiomyopathy (4%) and valvular heart disease (2%). Procedural success occurred in 83%, with six major complications. After a median follow-up of 231 days (lower quartile 133, upper quartile 631), the primary outcome occurred in 28% of patients. There were two non-arrhythmic deaths (4%). At a median follow-up of 193 days (129–468), the primary outcome occurred in 19% of patients with ICM, while VT storm/appropriate shocks occurred in three patients (17%).ConclusionsOur real-world registry confirms that VT ablation is safe, and is associated with high acute procedural success and long-term outcomes comparable with randomised controlled studies.

Sign in / Sign up

Export Citation Format

Share Document